BioMarin Pharmaceutical | BMRN - Acción





Acción Cambio Fecha
Acadia Pharmaceuticals USD 31.57M 3.1M 2026-03
Agios Pharmaceuticals USD 35.09M 2.17M 2026-03
Alnylam Pharmaceuticals USD 200.15M 117.43M 2026-03
Amgen USD 6.19B 39M 2026-03
Bayer EUR 12.34B 3M 2025-12
Biogen USD 1.95B 219.1M 2026-03
BioMarin Pharmaceutical USD 1.27B 25.66M 2026-03
Gilead Sciences USD 1.91B 140M 2026-03
Incyte USD 115.62M 14.56M 2026-03
Insmed USD 132.91M 841K 2026-03
Ionis Pharmaceuticals USD 5.56M 4.49M 2026-03
Moderna USD 146M 7M 2026-03
Neurocrine Biosciences USD 64.5M 4.5M 2026-03
PTC Therapeutics USD 75.57M 4.08M 2026-03
Puma Biotechnology USD 9.48M 885K 2025-09
Regeneron Pharmaceuticals USD 3.1B 97.2M 2026-03
Roche Holding CHF 7.6B 9M 2025-06
Sanofi EUR 22.69B 1.81B 2025-12
Sarepta Therapeutics USD 1B 86.37M 2026-03
Ultragenyx Pharmaceutical USD 55M 3M 2026-03
United Therapeutics USD 178.3M 4.8M 2026-03
Vertex Pharmaceuticals USD 1.77B 79.9M 2026-03